Ziprasidone-d8

• CAT Number: S000405
• CAS Number: 1126745-58-1
• Molecular Formula: C21H13D8ClN4OS
• Molecular Weight: 420.98
• Purity: ≥95%
• IUPAC Name: 5-[2-[4-(1,2-benzothiazol-3-yl)-2,2,3,3,5,5,6,6-octadeuteriopiperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one
• InChI: InChI=1S/C21H21ClN4OS/c22-17-13-18-15(12-20(27)23-18)11-14(17)5-6-25-7-9-26(10-8-25)21-16-3-1-2-4-19(16)28-24-21/h1-4,11,13H,5-10,12H2,(H,23,27)/i7D2,8D2,9D2,10D2
• InChIKey: MVWVFYHBGMAFLY-UFBJYANTSA-N
• SMILES: C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54

Ziprasidone-d8（Cat No.:S000405） is a deuterated version of ziprasidone, where eight hydrogen atoms are replaced with deuterium. This alteration enhances the drug’s metabolic stability, making it particularly useful for pharmacokinetic and metabolic research. Ziprasidone is an antipsychotic medication used primarily to treat schizophrenia and bipolar disorder. It functions by modulating the activity of various neurotransmitters in the brain, including dopamine and serotonin, which help to stabilize mood and reduce psychotic symptoms.